Aileron Therapeutics, Inc.
5 clinical trials · Sponsor
◉ Watch Aileron Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| A Study of ALRN-6924 for Protection of Chemotherapy-Induced Side Effects in Patients With TP53-Mutant Breast Cancer (NCT05622058) | Aileron Therapeutics, Inc. | 2023-01-09 |
| A Study of ALRN-6924 for the Prevention of Chemotherapy-induced Side Effects (Chemoprotection) (NCT04022876) | Aileron Therapeutics, Inc. | 2019-09-03 |
Track Aileron Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.